Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Brown

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
The Lancet. HIV|June 25, 2026
Cost-effectiveness of emergency department opt-out testing for HIV in England: a modelling studyJosephine G Walker, Rebecca F Baggaley, Gareth Myring, et al.
Journal of Toxicology and Environmental Health. Part B, Critical Reviews|July 7, 2025
Insights derived from testing a library of per- and polyfluoroalkyl substances (PFAS) in a battery of new approach methods (NAMs)Grace Patlewicz, Richard Judson, Katie Paul Friedman, et al.
Urologic Oncology|October 28, 2025
Efficacy of sacituzumab govitecan after enfortumab vedotin in advanced urothelial carcinoma: Analysis of the UNITE studyTanya Jindal, Cindy Y Jiang, Omar Alhalabi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 15, 2026
Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In OncologyThomas W Flaig, Philippe E Spiess, Michael Abern, et al.
European Urology|September 15, 2025
Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE StudyTanya Jindal, Cindy Y Jiang, Omar Alhalabi, et al.
Nature Genetics|May 7, 2021
Uncovering genetic mechanisms of hypertension through multi-omic analysis of the kidneyJames M Eales, Xiao Jiang, Xiaoguang Xu, et al.
Cell|November 25, 2021
From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's diseaseAlastair J H Brown, Sophie J Bradley, Fiona H Marshall, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
The Lancet. HIV|June 25, 2026
Cost-effectiveness of emergency department opt-out testing for HIV in England: a modelling studyJosephine G Walker, Rebecca F Baggaley, Gareth Myring, et al.
Journal of Toxicology and Environmental Health. Part B, Critical Reviews|July 7, 2025
Insights derived from testing a library of per- and polyfluoroalkyl substances (PFAS) in a battery of new approach methods (NAMs)Grace Patlewicz, Richard Judson, Katie Paul Friedman, et al.
Urologic Oncology|October 28, 2025
Efficacy of sacituzumab govitecan after enfortumab vedotin in advanced urothelial carcinoma: Analysis of the UNITE studyTanya Jindal, Cindy Y Jiang, Omar Alhalabi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 15, 2026
Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In OncologyThomas W Flaig, Philippe E Spiess, Michael Abern, et al.
European Urology|September 15, 2025
Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE StudyTanya Jindal, Cindy Y Jiang, Omar Alhalabi, et al.
Nature Genetics|May 7, 2021
Uncovering genetic mechanisms of hypertension through multi-omic analysis of the kidneyJames M Eales, Xiao Jiang, Xiaoguang Xu, et al.
Cell|November 25, 2021
From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's diseaseAlastair J H Brown, Sophie J Bradley, Fiona H Marshall, et al.
Pageof 12